Safety and Effectiveness of Prucalopride in Children with Functional Constipation with and without Upper Symptoms.
dc.contributor.author | Velez, Alejandro | |
dc.contributor.author | Kaul, Ajay | |
dc.contributor.author | El-Chammas, Khalil I | |
dc.contributor.author | Knowlton, Lesley | |
dc.contributor.author | Madis, Erick | |
dc.contributor.author | Sahay, Rashmi | |
dc.contributor.author | Fei, Lin | |
dc.contributor.author | Stiehl, Sarah | |
dc.contributor.author | Santucci, Neha R | |
dc.coverage.spatial | Switzerland | |
dc.date.accessioned | 2024-01-10T13:39:43Z | |
dc.date.available | 2024-01-10T13:39:43Z | |
dc.date.issued | 2024-01-04 | |
dc.identifier.issn | 1174-5878 | |
dc.identifier.issn | 1179-2019 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/38175354 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/191987 | en |
dc.description.abstract | INTRODUCTION: Pediatric prucalopride studies for treatment of gastrointestinal (GI) disorders have reported mixed results. We aimed to assess the safety and effectiveness of prucalopride in functional constipation (FC) with and without upper GI symptoms. METHODS: Retrospective data on patients with FC receiving combined prucalopride and conventional therapy was compared with those receiving conventional therapy alone within 12 months. Thirty patients on combined therapy and those on conventional therapy were each matched on the basis of age, gender, race, and presence of fecal soiling. Response (complete, partial, or no resolution) was compared. Similarly, response to concurrent functional upper GI symptoms (postprandial pain, bloating, weight loss, vomiting, early satiety, or nausea) and dysphagia, as well as adverse effects, were evaluated in the combined group. RESULTS: Mean age of 57 cases was 14.7 ± 4.9 years and 68% were female. Comorbidities included functional upper GI (UGI) symptoms (84%), dysphagia (12%), mood disorders (49%), and hypermobility spectrum disorder (37%). Unmatched cases reported 63% improvement to FC; response did not differ between the matched cohorts (70% versus 76.6%, p = 0.84). Cases showed a 56% improvement in functional UGI symptoms and 100% in dysphagia. Adverse effects were reported in 30%, abdominal cramps being most common. Four (7%) patients with a known mood disorder reported worsened mood, of which two endorsed suicidal ideation. CONCLUSION: Prucalopride efficaciously treated concurrent UGI symptoms and dysphagia in constipated pediatric patients and was overall well tolerated. Preexisting mood disorders seemed to worsen in a small subset of cases. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | Springer Nature | |
dc.subject | 32 Biomedical and Clinical Sciences | |
dc.subject | 3202 Clinical Sciences | |
dc.subject | Neurosciences | |
dc.subject | Pediatric | |
dc.subject | Mental Health | |
dc.subject | Pain Research | |
dc.subject | Digestive Diseases | |
dc.subject | Clinical Research | |
dc.subject | Patient Safety | |
dc.subject | 6.1 Pharmaceuticals | |
dc.subject | 6 Evaluation of treatments and therapeutic interventions | |
dc.subject | Oral and gastrointestinal | |
dc.title | Safety and Effectiveness of Prucalopride in Children with Functional Constipation with and without Upper Symptoms. | |
dc.type | Article | |
dc.identifier.pmid | 38175354 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/191987/2/FINAL PUBLISHED.pdf | |
dc.identifier.doi | 10.1007/s40272-023-00612-8 | |
dc.identifier.doi | https://dx.doi.org/10.7302/21988 | |
dc.identifier.source | Paediatr Drugs | |
dc.description.version | Published online | |
dc.date.updated | 2024-01-10T13:39:37Z | |
dc.identifier.orcid | 0000-0003-3533-1240 | |
dc.description.filedescription | Description of FINAL PUBLISHED.pdf : Published version | |
dc.identifier.startpage | 1 | |
dc.identifier.endpage | 9 | |
dc.identifier.name-orcid | Velez, Alejandro; 0000-0003-3533-1240 | |
dc.identifier.name-orcid | Kaul, Ajay | |
dc.identifier.name-orcid | El-Chammas, Khalil I | |
dc.identifier.name-orcid | Knowlton, Lesley | |
dc.identifier.name-orcid | Madis, Erick | |
dc.identifier.name-orcid | Sahay, Rashmi | |
dc.identifier.name-orcid | Fei, Lin | |
dc.identifier.name-orcid | Stiehl, Sarah | |
dc.identifier.name-orcid | Santucci, Neha R | |
dc.working.doi | 10.7302/21988 | en |
dc.owningcollname | Pediatrics and Communicable Diseases, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.